Novogenia AG Sustainability Reports
The company operates as a biotechnology and healthcare entity specializing in human genetics, molecular analysis, and personalized product development. It develops and sells genetically customized products such as dietary supplements and cosmetics based on scientific lab analysis data.
Sector: Professional & technical services
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 391200XJOD6U0EW7OE14
FIGI: BBG0137Y8NY4
5 reports from 2021 to 2025
